You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 118 No. 2, February 2000 TABLE OF CONTENTS
  Archives
  •  Online Features
  Case Reports and Small Case Series
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on ISI (2)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

Photorefractive Keratectomy for Correction of Epikeratophakia Regression

Arch Ophthalmol. 2000;118:281-282.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Excimer laser photorefractive keratectomy (PRK) is widely used for the correction of myopia, astigmatism, and hyperopia.1-2 It has also been used for correction of astigmatism after penetrating keratoplasty.3

Epikeratophakia has been used in the treatment of nontolerant contact lens keratoconous patients.4-5 The epigrafts were made from machined corneal tissue that was found unsuitable for penetrating keratoplasty. Long-term follow-up of pediatric patients who underwent epikeratoplasty for optical correction of aphakia and were corrected for emmetropia revealed that later in life there is delayed myopic regression of the treated eye, which required further correction.6-7 In their patients, Colin et al8 failed to correct this myopic regression with PRK. We describe our experience with PRK for correction of delayed myopic regression of epikeratophakia in 4 eyes.

Design

All procedures were performed in the cornea and refractive surgery unit of The Goldschleger Eye Institute, Sheba Medical Center, Tel-Hashomer, Israel.

Four eyes of 2 twin sisters . . . [Full Text of this Article]


Results

Comment
Hirsh Ami, MD; Solberg Yoram, MD, PhD; Cahana Michael, MD; Avni Isaac, MD
Tel-Hashomer, Israel

Corresponding author: Yoram Solberg, MD, PhD, The Goldschleger Eye Institute, Sheba Medical Center, Tel-Hashomer 52621, Israel (e-mail: solberg@inter.net.il).







HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2000 American Medical Association. All Rights Reserved.